SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · IEX Real-Time Price · USD
2.130
+0.040 (1.91%)
At close: Jul 19, 2024, 4:30 PM
2.210
+0.080 (3.76%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

SCYNEXIS Revenue

SCYNEXIS had revenue of $140.39M in the twelve months ending March 31, 2024, with 2,436.77% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.37M with 21.50% year-over-year growth. In the year 2023, SCYNEXIS had annual revenue of $140.14M with 2,652.72% growth.

Revenue (ttm)
$140.39M
Revenue Growth
+2,436.77%
P/S Ratio
0.57
Revenue / Employee
$4,840,862
Employees
29
Market Cap
80.47M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023140.14M135.05M2,652.72%
Dec 31, 20225.09M-8.07M-61.32%
Dec 31, 202113.16M--
Dec 31, 20200--
Dec 31, 2019121.00K-136.00K-52.92%
Dec 31, 2018257.00K--
Dec 31, 2017257.00K--
Dec 31, 2016257.00K--
Dec 31, 2015257.00K-999.00K-79.54%
Dec 31, 20141.26M-15.60M-92.55%
Dec 31, 201316.86M20.00K0.12%
Dec 31, 201216.84M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Protalix BioTherapeutics 59.65M
DBV Technologies 14.94M
Ikena Oncology 3.85M
Serina Therapeutics 3.15M
Nutriband 2.02M
Chimerix 41.00K
Revenue Rankings